PF-562271 HCl

FAK inhibitor active pharmaceutical ingredient

Synephrine

active pharmaceutical ingredient

بنزوكايين

local anesthetic active ingredient

1,1-Dimethylethyl (6E)-7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-5-hydroxy-3-oxo-6-heptenoate

statin HMG-CoA reductase inhibitor

(E)-Methyl 7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3-hydroxy-5-oxohept-6-enoate

Pharmaceutical intermediate for statin synthesis

(2E)-3-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-2-propenal

Impurity reference standard for fluvastatin